Company Filing History:
2 out of 1,386 
1 out of 1 
1 out of 1 Years Active: 2008-2009
Title: The Innovations of Stuart L Bursten
Introduction
Stuart L Bursten is a notable inventor based in Napa, CA (US). He has made significant contributions to the field of lipid mediators, particularly those derived from omega-3 polyunsaturated fatty acids (PUFAs). With a total of 2 patents, his work focuses on developing compounds that enhance the bioactivity and tissue half-life of these mediators.
Latest Patents
Bursten's latest patents include "Analogues of lipid mediators derived from ω-3 PUFAs and methods of use." This invention is directed towards compounds that are analogues of lipid mediators derived from eicosapentaenoic acid (EPA). These analogues are designed to have a longer tissue half-life and enhanced bioactivity, making them useful in treating a variety of diseases. The conditions that may benefit from these analogues include inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic, and gastrointestinal diseases.
Career Highlights
Throughout his career, Bursten has worked with esteemed organizations such as Brigham and Women's Hospital, Inc. and Resolvyx Pharmaceuticals, Inc. His experience in these institutions has allowed him to further his research and development in the field of lipid mediators.
Collaborations
Some of his notable coworkers include Daniel W Goodman and Michael R Hanley. Their collaboration has likely contributed to the advancements in Bursten's research and innovations.
Conclusion
Stuart L Bursten's work in the field of lipid mediators showcases his dedication to advancing medical treatments through innovative compounds. His patents reflect a commitment to addressing various health conditions, making a significant impact in the medical community.